Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3622476
Max Phase: Preclinical
Molecular Formula: C61H91NO20
Molecular Weight: 1158.39
Molecule Type: Small molecule
Associated Items:
ID: ALA3622476
Max Phase: Preclinical
Molecular Formula: C61H91NO20
Molecular Weight: 1158.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)N[C@H]1[C@@H](C)O[C@@H](O[C@H]2C/C=C(\C)[C@@H]3C=C[C@@H]4[C@@H](O[C@H]5C[C@@H](O[C@H]6C[C@@H](O)[C@@H](O[C@@H]7C[C@@H](O)[C@@H](OC)[C@H](C)O7)[C@H](C)O6)[C@@H](O)[C@H](C)O5)[C@@H](C)C[C@H](C)[C@H]4[C@]3(C)C(=O)C3=C(O)[C@@]4(C[C@@H](C)C(CO)=C[C@H]4/C=C/2C)OC3=O)C[C@]1(C)O
Standard InChI: InChI=1S/C61H91NO20/c1-27-14-17-42(78-47-25-59(10,71)54(35(9)77-47)62-58(70)73-13)28(2)19-37-20-36(26-63)31(5)24-61(37)56(68)48(57(69)82-61)55(67)60(11)39(27)16-15-38-49(60)29(3)18-30(4)51(38)80-46-23-43(50(66)32(6)74-46)79-44-22-41(65)53(34(8)76-44)81-45-21-40(64)52(72-12)33(7)75-45/h14-16,19-20,29-35,37-47,49-54,63-66,68,71H,17-18,21-26H2,1-13H3,(H,62,70)/b27-14+,28-19+/t29-,30-,31+,32-,33-,34-,35+,37+,38-,39-,40+,41+,42-,43+,44-,45+,46-,47-,49+,50-,51-,52-,53-,54-,59-,60+,61-/m0/s1
Standard InChI Key: SPSJROOGUDRAFL-GGYAFDJOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1158.39 | Molecular Weight (Monoisotopic): 1157.6134 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Cruz PG, Fribley AM, Miller JR, Larsen MJ, Schultz PJ, Jacob RT, Tamayo-Castillo G, Kaufman RJ, Sherman DH.. (2015) Novel Lobophorins Inhibit Oral Cancer Cell Growth and Induce Atf4- and Chop-Dependent Cell Death in Murine Fibroblasts., 6 (8): [PMID:26288688] [10.1021/acsmedchemlett.5b00127] |
Source(1):